I. Petersen

Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population‐based study

M. Hotopf, S. Saxena, A. Bottle, 2022, Alimentary pharmacology & therapeutics.

Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease

S. Saxena, A. Bottle, H. Creese, 2023, Alimentary pharmacology & therapeutics.

DOP85 Rising depression and antidepressant use amongst inflammatory bowel disease patients

M. Hotopf, S. Saxena, A. Bottle, 2019, Journal of Crohn's and Colitis.

P166 Impact of consultation frequency and time to diagnosis on subsequent Inflammatory Bowel Disease outcomes

S. Saxena, A. Bottle, R. Pollok, 2021, Journal of Crohn's and Colitis.

Letter: diagnostic delay in inflammatory bowel disease—Authors' reply

S. Saxena, A. Bottle, N. Jayasooriya, 2023, Alimentary pharmacology & therapeutics.

Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort.

P. White, W. Hamilton, I. Petersen, 2006, QJM : monthly journal of the Association of Physicians.

Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database

Anne M Johnson, I. Petersen, D. Livermore, 2007, BMJ : British Medical Journal.

Type 2 diabetes mellitus in people with severe mental illness: inequalities by ethnicity and age. Cross‐sectional analysis of 588 408 records from the UK

R. Stewart, M. Prince, J. Nazroo, 2017, Diabetic medicine : a journal of the British Diabetic Association.

Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database

Anne M Johnson, D. Livermore, A. Hayward, 2007, BMJ : British Medical Journal.